Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 11th Nov 2013 08:50

Associated British Foods: Barclays downgrades to equal-weight with a target price of 2100p.Bovis Homes Group: Deutsche Bank moves target price from 1001p to 1008p maintaining a buy recommendation.British Land: Deutsche Bank downgrades to sell with a target price of 520p.British Sky Broadcasting: Nomura reduces target price from 1040p to 850p and downgrades from buy to reduce. Goldman Sachs cuts target price from 1120p to 1070p, while reiterating its buy recommendation.BT Group: JP Morgan increases target price from 380p to 420p upgrading from neutral to overweight. Citi ups target price from 400p to 430p retaining a buy recommendation. UBS cuts target price from 310p to 290p and stays with its sell recommendation.Cable & Wireless Communications: Jefferies shifts target price from 45p to 48p and retains a hold recommendation.Carr's Milling: Investec places both its target price (prev.: 1710p) and its buy recommendation under review.Cobham: Investec cuts target price from 275p to 230p retaining its sell recommendation.Dignity: Investec raises target price from 1562p to 1583p and upgrades from add to buy.Faroe Petroleum: Panmure Gordon moves target price from 182p to 188p and retains a buy recommendation. Westhouse Securities shifts target price from 175p to 185p and maintains a buy recommendation.FlyBe: Liberum Capital initiates with a target price of 90p and a buy recommendation.Gemfields: Investec moves target price from 30p to 37.5p and reiterates a buy recommendation.International Consolidated Airlines Group: Citi raises target price from 380p to 535p and stays with its buy recommendation. HSBC takes target price from 405p to 420p maintaining an overweight rating. Credit Suisse increases target price from 345p to 443p and reiterates an outperform rating.International Personal Finance: RBC Capital shifts target price from 700p to 695p and maintains an outperform rating.ITV: Citi ups target price from 180p to 191p, while downgrading from buy to neutral. Goldman Sachs lowers target price from 240p to 237p and retains a buy recommendation.Lonmin: Investec places its target price (prev.: 266p), while leaving its sell recommendation unaltered.Morgan Advanced Materials: Investec places its target price (prev.: 410p) under review, while keeping its buy recommendation.Paragon Group: RBC Capital ups target price from 350p to 390p upgrading to outperform.Rentokil Initial: JP Morgan moves target price from 75p to 86p, while leaving its underweight rating unchanged.Royal Bank of Scotland: Jefferies raises target price from 390p to 441p and keeps a buy recommendation.RSA Insurance Group: Citi reduces target price from 146p to 126p downgrading from buy to neutral. Panmure Gordon moves target price from 98p to 117p, but still recommends selling. Credit Suisse lowers target price from 125p to 110p and downgrades to underperform.Shire: Panmure Gordon raises target price from 2850p to 3100p and keeps a buy recommendation.Tullett Prebon: UBS cuts target price from 315p to 290p and maintains its sell recommendation.Verona Pharma: N+1 Singer initiates with a target price of 5.1p and a buy recommendation.Wincanton: Investec ups target price from 75p to 122p, while downgrading from buy to hold.
More News
5 Nov 2015 10:50

Verona Pharma Completes Patient Enrolment For RPL554 Studies

Read more
14 Oct 2015 10:40

Verona Pharma: First Patients Dosed In RPL554 Combination Study

Read more
29 Sep 2015 09:18

Verona Pharma rallies on positive drug study results

(ShareCast News) - Shares in Verona Pharma rallied after it announced positive headline data from the third and final part of a clinical study on its RPL554 drug for the treatment of chronic obstructive pulmonary disease. The drug development company said the primary objective of this part of the st

Read more
29 Sep 2015 07:58

Verona Pharma Shares Up 10% On Good RPL554 Study Results

Read more
8 Sep 2015 08:28

Verona Pharma plunges as interim loss widens

(ShareCast News) - Shares in Verona Pharma plunged over 12% early on Tuesday, after the pharmaceutical company posted a wider interim pre-tax loss. The London-listed company, which attributed the wider loss to an increase in research and development spending, saw its pre-tax loss for the six months

Read more
8 Sep 2015 07:23

Verona Pharma Loss Widens On Higher Research And Development Spending

Read more
12 Jun 2015 11:19

LONDON MIDDAY BRIEFING: Greece Remains Optimistic For Debt Deal

Read more
12 Jun 2015 10:27

WINNERS & LOSERS: Petra Diamonds Loses Sparkle On Lower Quality Stones

Read more
12 Jun 2015 09:46

Verona Pharma to launch secondary listing in Germany

AIM-listed drug developer Verona Pharma has carried out a second listing in Germany. The move will be a way of further raising its profile within continental Europe and to increase the potential for investors in German-speaking Europe to trade in the company's shares, it said. The group will be lis

Read more
12 Jun 2015 08:40

Verona Pharma Takes Secondary Listing In Germany (ALLISS)

Read more
11 Jun 2015 07:52

Verona Pharma Begins Phase 2A Dose-Finding Trial Of RPL554 In Asthma

Read more
11 Jun 2015 07:32

LONDON MORNING BRIEFING: Royal Mail Falls, RBS Gains On UK Govt Moves

Read more
11 Jun 2015 05:26

AGM, EGM Calendar - Week Ahead

Read more
10 Jun 2015 15:00

AGM, EGM Calendar - Week Ahead

Read more
10 Jun 2015 05:30

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.